Right Ventricular Cardiomyocyte Dysfunction and Arrhythmogenesis in a Bleomycin-induced Mouse Model of Group 3 Pulmonary Hypertension
Group 3 pulmonary hypertension (PH) occurs when lung diseases induce hypoxic vasoconstriction and pulmonary vascular remodeling. The increase in pulmonary vascular resistance elevates right ventricular (RV) afterload leading to progressive ventricular dysfunction. The mechanisms underlying cardiomyocyte dysfunction in Group 3 PH remain poorly characterized, despite RV pathology representing a critical component of disease progression. Using a mouse model of intratracheal bleomycin-induced PH, we tested the hypothesis that RV function and cardiomyocyte excitation-contraction coupling (ECC) are impaired in PH. Male and female mice were administered intratracheal saline (Sham) or bleomycin to induce PH and assess for sex differences across cardiac parameters. Langendorff-perfused working heart preparations revealed that PH mice display greater RV pressure development, elevated end diastolic pressure, and more spontaneous ventricular arrhythmias versus Sham. Structurally, hearts of PH mice exhibited increased RV hypertrophy and fibrosis versus Sham, with the hypertrophic response more pronounced in males versus females. To assess Ca 2+ dynamics and cellular contractile function, enzymatically isolated cardiomyocytes were subjected to electrical field stimulation (0.5-4 Hz, fura-2 dye). RV cardiomyocyte ECC was impaired in PH versus Sham mice, including elevated diastolic Ca 2+ and shorter diastolic sarcomere lengths, depressed Ca 2+ transient and sarcomere contraction amplitudes, and slower Ca 2+ decay rates with slower sarcomere relaxation. Left ventricular (LV) cardiomyocytes did not display these changes. Taken together, these data indicate impairment in RV ECC in the bleomycin-induced PH model, highlighting multiple Ca 2+ handling abnormalities that may contribute to the RV dysfunction and arrhythmogenesis observed clinically in PH.
Authors
- Charles Elbert Norton (ORCID: https://orcid.org/0000-0001-9442-4039)
- Timothy L. Domeier (ORCID: https://orcid.org/0000-0003-0340-6551)
- Jessica Cayton (ORCID: https://orcid.org/0000-0002-6438-5793)
- Andrew J. Behrmann (ORCID: https://orcid.org/0000-0001-5489-4335)
- Matthew R. Hayden (ORCID: https://orcid.org/0000-0002-9680-6644)
- Keith Nyanyo
- Arooj Shahid (ORCID: https://orcid.org/0009-0008-7916-9250)
- Ami Patel
- Scott Roselli
Institutions
- University of Missouri (US)
Publication Details
- Journal
- American Journal of Physiology-Heart and Circulatory Physiology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1152/ajpheart.90083.2026
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00